Skip to main content
OpenTrials

Clinical trial condition

Histiocytic Disorders, Malignant

Explore clinical trials studying Histiocytic Disorders, Malignant. Study availability and eligibility vary by location and protocol.

260 public trials 43 recruiting studies
Refine in advanced search Browse all conditions

Histiocytic Disorders, Malignant trial results

Completed

Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL

NCT00546793

Conditions
CLL, Chronic Disease, Dendritic Cell Sarcoma, Interdigitating, +35 more
Locations
  • Lewis Cancer Center and Research Pavilion Savannah, Georgia, United States
  • Cancer Care at Saint Clare's/Saint Clares Hospital Oncology & Hematology Specialists, P.A. Denville, New Jersey, United States
  • Morristown Memorial Hospital Morristown, New Jersey, United States
  • New York Hospital Weill Cornell Medical Center New York, United States
View Trial Details
Completed

Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients With Cancer

NCT00369564

Conditions
Burkitt Lymphoma, Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +46 more
Locations
  • Lee Cancer Care of Lee Memorial Health System Fort Myers, Florida, United States
  • Butterworth Hospital at Spectrum Health Grand Rapids, Michigan, United States
  • Children's Hospitals and Clinics of Minnesota - Minneapolis Minneapolis, Minnesota, United States
  • Hackensack University Medical Center Cancer Center Hackensack, New Jersey, United States
View Trial Details

Related conditions